SciELO - Scientific Electronic Library Online

 
vol.44 issue4Elevated yield of Monacolin K in Monascus purpureus by fungal elicitor and mutagenesis of UV and LiClHuman Sociogenetics author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Biological Research

Print version ISSN 0716-9760

Biol. Res. vol.44 no.4 Santiago  2011

http://dx.doi.org/10.4067/S0716-97602011000400011 

Biol Res 44: 383-391, 2011

Research Articles

Mycoplasma hyorhinis and Mycoplasma fermentans induce cell apoptosis and changes in gene expression profiles of 32D cells

 

Wenbin Liu1 and Chengchao Shou2

1 College of Health Science and Nursing, Wuhan Polytechnic University, No. 68 Southern Xuefu Road, Changqing Garden, Wuhan 430023, China Tel: 86-13296676983 Fax: 86-27-83956940 Email: liuwenbin_1@yeah.net

2 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute, Beijing 100142, China.


ABSTRACT

Infection of mycoplasmas has been linked to various human diseases including arthritis, pneumonia, infertility and cancer. While Mycoplasma hyorhinis and Mycoplasma fermentans have been detected in gastric adenocarcinomas, the mechanisms underlyine the pathogenesis are unknown. In this study, cell growth kinetics, Hoechst 33258 staining, DNA ladder assays, Western blotting analysis and cDNA microarray assays were performed to investigate the roles of M. hyorhinis and M. fermentans during infection of mammalian cells. Our data demonstrated that these mycoplasmas inhibid the growth of immortalised cell lines (32D and COS-7) ane tumor cell lines (HeLa and AGS). In addition, the infection of the 32D cell line with M. hyorhinis and M. fermentans induced compression of the nucleus, degradation of the cell genome and dysregulation of the expression of genes related to proliferation, apoptosis, tumorigenesis, signaling pathway and metabolism. Apoptosis related proteins Bcl-2, Bid and p53 were down-regulated, Fas was up-regulated and Bax was dysregulated in mycoplasma-infected 32D cells. Together, our data demonstrated that infection of mycoplasmas inhibitd cele growts through modification of gene expression profiles and post-translation modification of proliferation and apoptosis related proteins.

Key terms: mycoplasma, apoptosis, gene expression profiles.


 

INTRODUCTION

Microbial infection causes many human diseases, such as dermatosis, tuberculosis, and even cervical carcinoma. Previous studies have demonstrated that infection of Helicobacter pylori could cause gastritis and gastric cancer (Correa, 1991; Parsonnet et al., 1991; Parsonnet et al., 1994). H. pylori also induces apoptosis of eukaryotic cells through bacterial molecules, such as vacuolating cytotoxin A (Vac A) (Yahiro et al., 1997; Gebert et al., 2003) and CagA, which is encoded by the cytotoxin-associated gene A. These virulence factors, along with host genetic and environmental factors, constitute a complex network to regulate chronic gastric injury and inflammation, which is involved in a multistep process leading to gastric carcinogenesis (Isomoto et al., 2010; Maeda and Mentis, 2007). Other bacteria, such as the mycoplasmas that cause pneumonia, arthritis and infertility, usually exist in human respiratory, alimentary and genital tracts and they are surface epithelial parasites requiring exogenous cholesterol for membrane stability and cell entry (Metz and Kraft, 2010; Roediger, 2004; Hartmann, 2009). Mycoplasmas have also been found in patients with gastric cancer, ovary carcinoma, colon cancer, breast carcinoma and lung cancer (Huang et al., 2001; Sasaki et al., 1995), suggesting a direct link between infection of mycoplasmas and cancen. Furthermore, Feng and Tsai reported that infection of C3H (mouse embryo fibroblast) and 32D (murine myeloid cell line) cells with Mycoplasma fermentans induced malignancy and transformation of these cells (Feng et al., 1999; Tsai et al., 1995).

Swine are the natural hosts of Mycoplasma hyorhinis, which has not been previously described as a human pathogen (Decker and Barden, 1971; Magnusson et al., 1998). However, our previous work showed the presence of M. hyorhinis in fresh gastric tumors. Further works found that M. hyorhinis promotes tumor cell migration, invasion and metastasis (Yang et al., 2010).

In order to know how M. hyorhinie affecte host cells, we studied the growth kinetics ane gene expression profiles of mycoplasma-infected cells and found that this bacterium inhibited cell growth, induced apoptosis and dysregulated host gene expression profiles. Tiess findings will be helpful to understand further the relationship among mycoplasma infection, cell growth and cell apoptosis.

MATERIALS AND METHODS

Antibodies, proteins, interleukin 3, and other reagents

Mouse anti-p-actin monoclonal antibody was purchased from NeoMarkers (Fremont, CA, USA). Goat anti-p53 polyclonal antibody, mouse anti-Bcl-2 monoclonal antibody, ant-Bax, anti-Bid and horseradish peroxidase (HRP)-conjugated goat anti-rabbit secondary antibody were purchased from Santa Cruz Biotech (Santa Cruz, CA, USA), Trizol reagent from Invitrogen (Carlsbad, CA, USA), [a-32P]dCTP (deoxycytidine triphosphate) from Furui Co. (Beijing, China), recombinant murine interleukin 3 (IL-3) from PeproTech EC Ltd (London, UK), Hoechst 33258 from Sigma-Aldrich (St. Louis, MO, USA) and RNase A from Zhongshan Biotechnology Company (Beijing, China).

Mycoplasma strains and culture medium

M. fermentans (incognitus strain) and M. hyorhinis (ATCC 17981) came from Dr. Zhanggai Guo (Capital Children Institute, Beijing, China). The mycoplasmas were grown in modified G-PPLO medium (67.2% PPLO, 20% rabbit serum, 10% yeast extract, 1% glucose, 0.2% phenol red, 1.6% NaOH, and 1,000 U of penicillin/ml).

Cells, cell culture, and cell infection with mycoplasmas

32D cells (murine hematopoietic cells) and WEHI-3B cells were provided by Dr. Zhang (Armed Forces Institute of Pathology, Washington, D.C. USA). The former were maintained in modified RPMI 1640 medium supplemented with 15% fetal calf serum and 5% WEHI-3B conditioned medium, which contained IL-3. WEHI-3B cells were maintained in RPMI 1640 medium supplemented with 15% fetal calf serum. Mycoplasmas were resuscitated from -80°C storage, grown in modified G-PPLO medium, passed twice, and then applied to infect cells in a ratio of 1,000 color change units/cell. COS-7 and HeLa cells were grown in Dulbecco's modified Eagle's medium with 10% fetal calf serum. AGS cells were grown in F12 nutrient medium with 10% fetal calf serum.

Analysis of cell apoptosis

(1). Hoechst 33258 staining. Mycoplasma free 32D cells, M. fermentans-infected and M. hyorhinis-infected 32D cells were harvested by centrifuge, washed by serum free RPMI 1640 once, suspended with 500 ì! 2 Mg/ml Hoechst 33258 in serum free RPMI 1640 for 10-15 minutes at 37°C Then stained 32D cells were checked with a fluorescence microscope. (2). DNA ladder analysis. 32D cells were infected with mycoplasmas for 10 weeks, harvested by centrifuge and lysed in RIPA buffer (25 mM Tris*HCl, pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS). Total DNAs were extracted with phenol/chloroform, digested with RNase A for 1 hour at 37°C to remove RNAs and analyzed by electrophoresis on 1.8% agarose gel. (3). Western blot. Mycoplasma free and mycoplasma-infected 32D cells were harvested by centrifuge, washed with phosphate-buffered saline (PBS) and lysed with RIPA buffer. 50 ìg total proteins were subjected to SDS-PAGE and transferred onto nitrocellulose membranes. The membranes were probed with antibodies against cell apoptosis related proteins and developed with enhanced chemiluminesence (ECL) system (Amersham Pharmacia Biotech Inc, Piscataway, NJ, USA).

cDNA microarray and clustering analysis

More than 1 x 107 mycoplasma free 32D cells, M. fermentans-infected and M. hyorhinis-infected 32D cells were collected, respectively, and total RNAs were extracted with the Trizol reagent according to the manufacturer's protocol. cDNA microarrays were manipulated by using 8 BiostarM-80s chips containing 8,000 sequenced mouse cDNAs (Biostar Genechip Inc, Shanghai, China). Images were collected using a scanner (ScanArray 4000; Packard BioScience, Billerica, MA, USA) loaded with GenePix Pro 3.0 software (Molecular Devices Corporation, Union City, CA, USA). To control for dye (Cy3 and Cy5)-dependent biases within this system, two of the hybridizations were repeated with the fluorescent labels reversed. For all experiments, gene expression was measured by hybridization of fluorescently labeled samples to cDNA microarrays. Up-regulated and down-regulated genes were determined using the significance analysis of microarray algorithm (SamCluster software; available at wujuli@yahoo. com).

RT-PCR analysis

More than 1x 108 each of mycoplasma free 32D cells, M. fermentans-infected and M. hyorhinis-infected 32D cells were collected, and total RNAs were extracted using the Trizol reagent. First-strand cDNAs were synthesized with 15 ìg of total RNAs, 0.5 ìg of random primers (Promega Corporation, Madison, WI, USA), 3 ìl of ribonuclease inhibitors (Takara Biotechnology Co. Ltd, Dalian, China), 1 ìg of oligo (dT) (Takara Biotechnology Co. Ltd), and 5 U of MMLV RT (Invitrogen) in a 50 ìl RT (reverse transcription) reaction mixture according to the manufacturer's instructions. PCR amplifications were performed in a 25 ìl reaction mixture for 30 cycles with the cDNA from the RT as template and the special primers (listed in Table I) and at different annealing temperatures, depending on the genes involved. PCR products were stored at -20°C for later use.

Northern blot analysis

Total RNAs were extracted from different 32D cells with the Trizol reagent as described above, and were quantified by spectrophotometry. 15 ìg of total RNAs was denatured, size-fractionated by electrophoresis on a formaldehyde agarose gel, and transferred onto positively charged membranes (Hybond-N+; Amersham Biosciences, Buckinghamshire, England). The RNA was cross-linked to the membrane with an ultraviolet crosslinker (Hoefer Pharmacia Biotech Inc., San Francisco, CA, USA) and heateg at 80°C for 2 hours. The PCR products were purified by using a DNA gel extraction kit (Qiagen, Hilden, Germany), labeled with [a-32P] deoxycytidine triphosphate by random priming with Prime-a-Gene Labeling System (Promega) and purified with a PCR purification kit (Qiagen, Hilden, Germany). Blots were hybridized with labeled cDNA probes in ExpressHyb Hybridization Solution (BD Biosciences Clontech, Palo Alto, CA, USA) according to the manufacturer's instructions. Membranes were then washed in 1x standard saline citrate (4.41 g Tris-sodium citrate, 8.77 g NaCl, 1,000 ml H2O, pH 7-8) with 0.5% (w/v) sodium dodecyl sulfate and exposed to autoradiography for one day to two weeks. As a control to demonstrate RNA integrity, membranes were rehybridized with a human glyceraldehyde-3-phosphate dehydrogenase cDNA probe. The blots were washed in sterile water containing 0.5% sodium dodecyl sulfate at 90-100"C for 15 minutes and then exposed to x-ray film to confirm the removal of the probe before the blots were reused. Density values were normalized against signals for 28S and 18S rRNA.

Statistical analysis

The data were analyzed by Pearson's c2 test or nonparametric tests using commercially available software (SPSS 10.0). Significance was defined as P<0.05. Data are presented as mean ± standard deviation (SD).



RESULTS

Mycoplasmas inhibit growth of cell lines

32D cells are murine hematopoietic cells and have been used to study spontaneous transformation after infection of M. fermentans (Feng et al., 1999), In order to determine whether infection of M. hyorhinis could induce apoptosis or malignant transformation of mammalian cells, we used mycoplasma free and mycoplasma-infected immortal (32D and COS-7) or cancer cell lines (HeLa and AGS) for proliferation assays. Our data showed that infection of 32D, COS-7, HeLa and AGS cells with M. fermentans and M. hyorhinis inhibitee growth rates based on comparisong to control cells (free of mycoplasmas) (Figure 1). The inhibitory effect oy M. hyorhinis on the growth rates of 32D and AGS cells was stronger than that of M. fermentans (Figure 1).

Mycoplasma infection induces apoptosis of 32D cells

When 32D cells were infected with M. fermentans and M. hyorhinis and cultured for more than 3 days, the morphology of mycoplasma-infected 32D cells changed. Most of them became smaller than that of pathogen-free cells, indicating cell shrinkage. As shown in Figure 2A, Hoechst 33258 staining showed that there were many small brilliant-blue dots dispersed in the nucleus of mycoplasma-free 32D cells; for M. fermentans-infected cells, the whole body of nucleus became brighter, denser and smaller, and the brilliant-blue dots almost disappeared; for M. hyorhinis-infected cells, there were much brighter large dots in the nucleus and the nuclei of some M. hyorhinis-infected cells became much larger, indicating enhanced DNA breakage in the nuclei that were associated with the shrinking of cell bodies. In some nuclei of M. hyorhinis-infected 32D cells, the nucleic substance moved to one side and became denser, whict meant apoptotic corpuscles, and some nuclei, were broken. This indicates that there were much more apoptotic cells in culture of M. hyorhinis-infected 32D cells. Even after 32D cell culture conditions were changed, such as the type of serum was changed, or the culture volume was increased, thereewere some apoptotic cells in mycoplasma-infected 32D culture.

Correlated with Hoechst 33258 staining for apoptosis, our data showed stronger DNA fragmentation in 32D cells infected with M. hyorhinis compareg to infection with M. fermentans, which was indicated by a clear DNA ladder in M. hyorhinis infected cells but no or a very weak DNA ladder in M. fermentans infected cells (Figure 2B).

Next, we analyzed the expression of several proteins related to apoptosis. In M. fermentans infected 32D cells, anti-apoptotic Bcl-2 was down-regulated apparently, but the expression of pro-apoptotic Bax appeared to be up-regulated. These data indicate that the M. fermentans infected cells were in an early stage of apoptosis. The expression of Bcl-2 in M. hyorhinis infected cells was also down-regulated apparently, but both pro-apoptotic proteins like Bax and Bid were down-regulated to a much greater extent, indicating a much stronger apoptosis induction by M. hyorhinis. This suggests that M. hyorhinis infected cells were in a late stage of apoptosis. We found that Bid was truncated at the early stage of apoptosis and degraded in cells at the late stage. The expression of p53 was also down-regulated in apoptotic cells. We did not detect FasL expression, but found slightly up-regulated Fas protein in mycoplasma-infected 32D cells (Figure 2C). The intensity of each protein band detected by Western blot was calculated with Photoshop CS 9.0 software and data are shown in Table II.

Change of gene expression profiles in mycoplasma-infected cells

In order to identify the genes responding to mycoplasma-infection, 32D cells, infected with M. hyorhinis or M. fermentans for four weeks and nine weeks, were used for cDNA microarray assays, respectively (Table III). The result from experimental replicates demonstrated a high degree of reproducibility (correlation coefficient 0.872-1.033) and the profiles of the gene expression were clearly different among cells infected for various time lengths (Supplementary Materials_Excel 1-8). For First and Second chips, there were 153 differentially expressed genes with a ratio 2 or 0.5 and the same trend of up-regulation or down-regulation. For Third and Fourth chips, there were 269 differentially expressed genes, for Fifth and Sixth chips, 245, and for Seventh and Eighth chips, 98 (Linked Results in Supplementary Materials).

According to the report of Feng (1999), after 4 to 5 weeks, 32D cellseare malignantly transformed by M. fermentans, indicating that thehperiod of 4 weeks is the turning point of malignant transformation of 32D cells, so we chose 32D cells infected with M. fermentans or M. hyorhinis for 4 weeks and 9 weeks to extract total RNAs for cDNA microarray assays. At 4 weeks, infection of mycoplasma enhanced protein degradation and apoptosis of 32D cells by down-regulation of Serine (or cysteine) proteinase inhibitor, F-box and WD-40 domain protein and Serine protease inhibitor 1-3, and up-regulation of Proteosome 26S subunit (non-ATPase), Proteosome subunit alpha5, Ubiquitin-conjugating enzyme 8, Cathepsin and Kallikrein binding protein. Septin 6 and Inhibitor of DNA binding 4 were up-regulated because of DNA damage in 32D cells and up-regulation of Complement component 3 and Fc receptor might contribute to inflammation. Down-regulation of Src-like adaptor protein, Regulator of G-protein signaling 2, G protein-coupled receptor 56, Suppression of tumorigenicity 7, TGF beta inducible early growth response, Cysteine-rich protein 2, Neuroblastoma myc-related oncogene 1, and up-regulation of Teratocarcinoma-derived growth factor, Cytokine inducible SH2-containing protein and X-box binding protein 1 might contribute to cell malignant transformation. At 9 weeks (after malignant transformation of 32D cells), infection of mycoplasma balanced protein degradation and cell apoptosis by down-regulation of Proteosome subunit beta 9, F-box and WD-40 domain protein 4, Ribosomal protein L22, Serine protease inhibitor 1-3, Eukaryotic translation initiation factor 2 alpha kinase, Ubiquitin-protein ligase UBE3B, and up-regulation of Cytochrome C, Caspase 7, Eukaryotic translation elongation factor 1 epsilon 1, Cathepsin, Ribosomal protein (large P2), Kallikrein binding protein and Serine (or cysteine) proteinase inhibitor. The regulation of DNA damage, inflammation and tumorigenicity related genes were similar to that of time point of 4 weeks (Supplementary Materials_Excel 1-8).





We performed gene clustering using significance analysis based on the microarray algorithm SamCluster program. Genes with similar expression patterns were clustered together. The different experiments were also clustered, and a dendrogram, illustrating the relationship between the expression patterns, is shown with arrays that have the most similar gene expression profiles and are clustered together with the shortest branches. As welld more than 200 genes were found that responded to mycoplasma infection significantly (Figure 3).

Because we found that mycoplasmal infection inhibited growth of mammalian cells and induced apoptosis of 32D cells, we examined some important genes related to cell proliferation and apoptosis. Twelve genes were selected for further investigation (Table I). Killikrein binding protein is an EGF binding protein and inhibits serine proteinase (Gao et al., 2003). It was up-regulated dramatically in all M. fermentans or M. hyorhinis-infected 32D cells. Regulator of G-protein signaling 2, which inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits (Chen et al., 1997; Reif and Cyster, 2000) was down-regulated in all M. fermentans or M. hyorhinis-infected 32D cells. Src-like adaptor protein is related to the Eck receptor tyrosine kinase, has SH3 and SH2 domains, and controls mitogenesis, T cell receptor signaling and Src protein function negatively (Holland et al., 2001; Lebigot et al., 2003). Cysteine-rich protein 2 is a ligand of the ERBB tyrosine kinase receptor and has an EGF (epidermal growth factor)-like domain. It interacts with TGFB1I1 (Kim-Kaneyama et al., 2005). G protein-coupled receptor 56 is involved in the development of gastric cancer (Okumura et al., 2004). Suppression of tumorigenicity 7 may act as a tumor suppressor (Hooi et al., 2006). They were all down-regulated in M. fermentans (9 weeks) or M. hyorhinis (4 and 9 weeks)-infected 32D cells. IL-1 receptor-associated kinase is involved in IL-1 biochemistry (Qin et al., 2004). Annexin A3 is an inhibitor of phospholipase A2, possesses anti-coagulant properties, and binds calcium and phospholipids (Sopkova et al., 2002). X-box binding protein 1 is a transcription factor and is involved in the differentiation of plasma cells, in endoplasmic reticulum stress, and in carcinogenesis, and is a component of the BMP signaling pathway (Fujimoto et al., 2003; Takahashi et al., 2002). Embigin may function as a regulator of cell/ECM interactions during development and in the homeostasis of normal adult tissues. Cytokine inducible SH2-containing protein forms part of a classical negative feedback system that regulates cytokine signal transduction. And it is involved in the negative regulation of cytokines that signal through inhibition of STAT5 trans-activation by suppressing its tyrosine phosphorylation (Matsumoto et al., 1997). They were all up-regulated in M. fermentans (9 weeks) or M. hyorhinis (4 and 9 weeks)-infected 32D cells. Clusterin expression distinguishes follicular dendritic cell tumors from other dendritic cell neoplasms. Clusterin/apolipoprotein J (CLU) is a secreted heterodimeric glycoprotein that is up-regulated during tumorigenesis, as well as during cell injury or death (Grogg et al., 2004; He et al., 2004; Trougakos and Gonos, 2004).iIt was only up-regulated in 32D cells after long-tere (9 weeks) infection of mycoplasmas.Results of above genes from cDNA microarrays, which indicated gene expression's dysregulation, were also confirmed with Northern blots (Figure 4) and the densitometric analysis of the bands (Table IV).







DISCUSSION

Previous studies have demonstrated that infection of H. pylori induces cell apoptosis by Vac A protein (de Freitas et al., 2004; Galgani et al., 2004; Menaker et al., 2004; Cho et al., 2003; Fischer et al., 2004) and Cag A (Isomoto et al., 2010; Maeda and Mentis, 2007). Our previous studies showed the presence of M. hyorhinis and M. fermentans in fresh gastric cancer samples, but whether the infection of these mycoplasmas could directly induce gastric cells apoptosis, ulcer or cancer is unknown.

In their research, Feng and colleagues (1999) did not study if M. fermentans inhibits growth or induce apoptosis before the malignant transformation of 32D cells. In our research, we used M. fermentans as a control bacterium and used 32D cell as a cell model. We followed the protocols described by Feng (1999) and explored if M. hyorhinis could inhibit growth, induce apoptosis or malignant transformation of mammalian cells. Yang (2010) has reported that infection of mammalian cells with M. hyorhinis could promote cell migration, invasion and metastasis. Consequently, our current experiments focus on cell apoptosis caused by M. hyorhinis. We found that both M. fermentans and M. hyorhinis induced apoptosis of 32D cells and dysregulated gene expression profiles in 32D cells. Especially M. hyorhinis inhibited growth of mammalian cells much more than M. fermentans and these results were consistent with our apoptosis analysis. When infected the mammalian cells with mycoplasmas for less than 48 hours, the growth of cells free of mycoplasam was similar to that of mycoplasma-infected cells. That means the transcription of some apoptosis genes, translation and post-translation modification of some apoptosis proteins are just starting. After 72 hours, we observed apparent growth inhibition of mycoplasma-infected cells. That means some of cells have undergone apoptosis. These results correlate with cDNA microarray assays, indicating that infection of mycoplasmas induce dysregulation of some proliferation or apoptosis-related genes that lead to decreased cell growth. Using Hoechst 33258 staining, DNA ladder assay and protein expression analysis, we have shown that some mycoplasma-infected 32D cells underwent apoptosis as shown by the data from Bax and Bid protein analysis. In Northern blot analysis, the band of cytokine inducible SH2-containing protein (from mRNA of M. fermentans-infected 32D cells) is not consistent with the data of the cDNA microarray. It is possibly because of manipulation error from the cDNA microarray or from Northern blot. The bands of the other nine genes are consistent with the data from the cDNA microarray with a validation ratio of 95%. From the data of cDNA microarray, we know that mycoplasma infection induced expression of protein degradation or cell apoptosis related genes. In M fermentans or M. hyorhinis-infected 32D cells, some protease inhibitors (e.g. serine or cysteine protease inhibitor) were down-regulated. But thiol protease Cathepsin S was just up-regulated only in M. hyorhinis-infected 32D cells.


Infection of mycoplasmas can simultaneously induce two contrary outcomes in host mammalian cells simultaneously: cell malignancy and immortalization, or cell apoptosis. It is possible that infection of mycoplasmas will kill the weakest host cells, and transform only small percentages into malignant tumor cells, such as cancer stem-like cells. Similarly, when treated with carcinogen phorbol ester for four weeks, the growth of 32D cells was inhibited (data not shown). Together, these data suggest that infection of mycoplasma or treatment with mutagen induces host cell apoptosis prior to the induction of transformation and malignancy. Other studies have shown that infection of mycoplasmas can promote carcinogenesis by other pathways, such as promoting metastasis (Yang et al., 2010). Mycoplasma can also control the size of tumors by unknown mechanisms. Thus, by inducing transformation of host cells into tumor cells, mycoplasma can evade the immune surveillance by modification or dysregulation of host cell proteins that cannot be recognized by the host immune system. Further works are needed to characterize the relationship among mycoplasma, gastric cancer and other gastric diseases, such as gastric ulcers and gastritis.

ACKNOWLEDGEMENTS

This work was supported by the National Natural Science Foundation of China (Grant no. 30130190 and 91029713).

We thanks Shiming Zhang for kindly providing the C3H, 32D and WEHI-3B cells, Wuju Li for kind help in gene clustering analysis, Yong Li for technical help in Northern blot and Guifang Cai for valuable suggestion to prepare this article.

REFERENCES

CHEN C, ZHENG B, HAN J, LIN SC (1997) Characterization of a novel mammalian RGS protein that binds to Galpha proteins and inhibits pheromone signaling in yeast. J Biol Chem 272:8679-8685.         [ Links ]

CHO SJ, KANG NS, PARK SY, KIM BO, RHEE DK, PYO S (2003) Induction of apoptosis and expression of apoptosis related genes in human epithelial carcinoma cells by Helicobacter pylori Vac A toxin. Toxicon 42:601-611.         [ Links ]

CORREA P (1991) Is gastric carcinoma an infectious disease? N Engl J Med 325:1170-1171.         [ Links ]

DECKER JL, BARDEN JA (1971) Mycoplasma hyorhinis swine arthritis. Arthritis Rheum 14:781.         [ Links ]

DEFREITAS D, URBANO M, GOULAO MH, DONATO MM, BALDAIA C, MARTINS MI, SOUTO P, GREGORIO C, FIGUEIREDO P, GOUVEIA H, ROMAOZINHO JM (2004) The effect of Helicobacter pylori infection on apoptosis and cell proliferation in gastric epithelium. Hepatogastroenterology 51:876-882.         [ Links ]

FENG SH, TSAI S, RODRIGUEZ J, LO SC (1999) Mycoplasmal infections prevent apoptosis and induce malignant transformation of interleukin-3-dependent 32D hematopoietic cells. Mol Cell Biol 19:7995-8002.         [ Links ]

FISCHER W, GEBERT B, HAAS R (2004) Novel activities of the Helicobacter pylori vacuolating cytotoxin: from epithelial cells towards the immune system. Int J Med Microbiol 293:539-547.         [ Links ]

FUJIMOTO T, ONDA M, NAGAI H, NAGAHATA T, OGAWA K, EMI M (2003) Upregulation and overexpression of human X-box binding protein 1 (hXBP-1) gene in primary breast cancers. Breast Cancer 10: 301-306.         [ Links ]

GALGANI M, BUSIELLO I, CENSINI S, ZAPPACOSTA S, RACIOPPI L, ZARRILLI R (2004) Helicobacter pylori induces apoptosis of human monocytes but not monocyte-derived dendritic cells: role of the cag pathogenicity island. Infect Immun 72:4480-4485.         [ Links ]

GAO G, SHAO C, ZHANG SX, DUDLEY A, FANT J, MA JX (2003) Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage. Diabetologia 46:689-698.         [ Links ]

GEBERT B, FISCHER W, WEISS E, HOFFMANN R, HAAS R (2003) Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 301:1099-1102.         [ Links ]

GROGG KL, LAE ME, KURTIN PJ, MACON WR (2004) Clusterin expression distinguishes follicular dendritic cell tumors from other dendritic cell neoplasms: report of a novel follicular dendritic cell marker and clinicopathologic data on 12 additional follicular dendritic cell tumor and 6 additional interdigitating dendritic cell tumors. Am J Surg Pathol 28:988-998.         [ Links ]

HARTMANN M (2009) Genital mycoplasmas. J Dtsch Dermatol Ges 7: 371-377.         [ Links ]

HE HZ, SONG ZM, WANG K, TENG LH, LIU F, MAO YS, LU N, ZHANG SZ, WU M, ZHAO XH (2004) Alterations in expression, proteolysis and intracellular localization of clusterin in esophageal squamous cell carcinoma. World J Gastroenterol 10:1387-1391.         [ Links ]

HOLLAND SJ, LIAO XC, MENDENHALL MK, ZHOU X, PARDO J, CHU P, SPENCER C, FU A, SHENG N, YU P, PALI E, NAGIN A, SHEN M, YU S, CHAN E, WU X, LI C, WOISETSCHLAGER M, AVERSA G, KOLBINGER F, BENNETT MK, MOLINEAUX S, LUO Y, PAYAN DG, MANCEBO HS, WU J (2001) Functional cloning of Src-like adaptor protein-2 (SLAP-2), a novel inhibitor of antigen receptor signaling. J Exp Med 194:1263-1276.         [ Links ]

HOOI CF, BLANCHER C, QIU W, REVET IM, WILLIAMS LH, CIAVARELLA ML, ANDERSON RL, THOMPSON EW, CONNOR A, PHILLIPS WA, CAMPBELL IG (2006) ST7-mediated suppression of tumorigenicity of prostate cancer cells is characterized by remodeling of the extracellular matrix. Oncogene 25:3924-3933.         [ Links ]

HUANG S, LI J, WU J, MENG L, SHOU CC (2001) Mycoplasma infection and different human carcinomas. World J Gastroenterol 7:266-269.         [ Links ]

ISOMOTO H, MOSS J, HIRAYAMA T (2010) Pleiotropic actions of Helicobacter pylori vacuolating cytotoxin, VacA. Tohoku J Exp Med 220:3-14.         [ Links ]

KIM-KANEYAMA JR, SUZUKI W, ICHIKAWA K, OHKI T, KOHNO Y, SATA M, NOSE K, SHIBANUMA M (2005) Uni-axial stretching regulates intracellular localization of Hic-5 expressed in smooth-muscle cells in vivo. J Cell Sci 118:937-949.         [ Links ]

LEBIGOT I, GARDELLIN P, LEFEBVRE L, BEUG H, GHYSDAEL J, QUANG CT (2003) Up-regulation of SLAP in FLI-1-transformed erythroblasts interferes with EpoR signaling. Blood 102:4555-4562.         [ Links ]

MAEDA S, MENTIS AF (2007) Pathogenesis of Helicobacter pylori infection. Helicobacter Suppl 1:10-14.         [ Links ]

MAGNUSSON U, WILKIE B, MALLARD B, ROSENDAL S, KENNEDY B (1998) Mycoplasma hyorhinis infection of pigs selectively bred for high and low immune response. Vet Immunol Immunopathol 61:83-96.         [ Links ]

MATSUMOTO A, MASUHARA M, MITSUI K, YOKOUCHI M, OHTSUBO M, MISAWA H, MIYAJIMA A, YOSHIMURA A (1997) CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood 89:3148-3154.         [ Links ]

MENAKER RJ, CEPONIS PJ, JONES NL (2004) Helicobacter pylori induces apoptosis of macrophages in association with alteration in the mitochondrial pathway. Infect Immun 72:2889-2898.         [ Links ]

METZ G, KRAFT M (2010) Effects of atypical infections with Mycoplasma and Chlamydia on asthma. Immunol Allergy Clin North Am 30:575-585.         [ Links ]

OKUMURA S, BABA H, KUMADA T, NANMOKU K, NAKAJIMA H, NAKANE Y, HIOKI K, IKENAKA K (2004) Cloning of a G-protein-coupled receptor that shows an activity to transform NIH3T3 cells and is expressed in gastric cancer cells. Cancer Sci 95:131-135.         [ Links ]

PARSONNET J, FRIEDMAN GD, VANDERSTEEN DP, CHANG Y, VOGELMAN JH, ORENTREICH N, SIBLEY RK (1991) Helicobacter pylori infection and gastric carcinoma. N Engl J Med 325:1127-1131.         [ Links ]

PARSONNET J, HANSEN S, RODRÍGUEZ L, GELB AB, WARNKE RA, JELLUM E, ORENTREICH N, VOGELMAN JH, FRIEDMAN GD (1994) Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330:1267-1271.         [ Links ]

QIN J, JIANG Z, QIAN Y, CASANOVA JL, LI X (2004) IRAK4 kinase activity is redundant for interleukin-1 (IL-1) receptor-associated kinase phosphorylation and IL-1 responsiveness. J Biol Chem 279:26748-26753.         [ Links ]

REIF K, CYSTER JG (2000) RGS molecule expression in murine B lymphocytes and ability to down-regulate chemotaxis to lymphoid chemokines. J Immunol 164:4720-4729.         [ Links ]

ROEDIGER WE (2004) Intestinal mycoplasma in Crohn's disease. Novartis Found Symp 263:85-93.         [ Links ]

SASAKI H, IGAKI H, ISHIZUKA T, KOGOMA Y, SUGIMURA T, TERADA M (1995) Presence of Streptococcus DNA sequence in surgical specimens of gastric cancer. Jpn J Cancer Res 86:791-794.         [ Links ]

SOPKOVA J, RAGUENES-NICOL C, VINCENT M, CHEVALIER A, LEWIT-BENTLEY A, RUSSO-MARIE F, GALLAY J (2002) Ca (2+) and membrane binding to annexin 3 modulate the structure and dynamics of its N terminus and domain III. Protein Sci 11:1613-1625.         [ Links ]

TAKAHASHI S, SUZUKI S, INAGUMA S, IKEDA Y, CHO YM, NISHIYAMA N, FUJITA T, INOUE T, HIOKI T, SUGIMURA Y, USHIJIMA T, SHIRAI T (2002) Down-regulation of human X-box binding protein 1 (hXBP-1) expression correlates with tumor progression in human prostate cancers. Prostate 50:154-161.         [ Links ]

TROUGAKOS IP, GONOS ES (2004) Functional analysis of clusterin/ apolipoprotein J in cellular death induced by severe genotoxic stress. Ann N Y Acad Sci 1019:206-210.         [ Links ]

TSAI S, WEAR DJ, SHIH JW, LO SC (1995) Mycoplasmas and oncogenesis: persistent infection and multistage malignant transformation. Proc Natl Acad Sci USA 92:10197-10201.         [ Links ]

YAHIRO K, NIIDOME T, HATAKEYAMA T, AOYAGI H, KURAZONO H, PADILLA PI, WADA A, HIRAYAMA T (1997) Helicobacter pylori vacuolating cytotoxin binds to the 140-kDa protein in human gastric cancer cell lines, AZ-521 and AGS. Biochem Biophys Res Commun 238:629-632.         [ Links ]

YANG H, QU L, MA H, CHEN L, LIU W, LIU C, MENG L, WU J, SHOU C (2010) Mycoplasma hyorhinis infection in gastric carcinoma and its effects on the malignant phenotypes of gastric cancer cells. BMC Gastroenterol 10:132.         [ Links ]


To whom correspondence should be addressed: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute, Beijing 100142, China. Tel: 86-10-88196766 Fax: 86-10-88122437 Email: scc@bjcancer.org

Received: November 22, 2010. In revised form: February 20, 2011. Accepted: March 2, 2011.

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License